NVAX Options: Straddles for September and October

NVAX, Novavax, is skyrocketing today. Below are straddles for September and October.

We said: "U.S. biotech company Novavax has a new kind of influenza vaccine that works against the swine flu virus in animals. It would have to get approval from the U.S. Food and Drug Administration before it could test the new vaccine in people and years of testing are likely to be required before such a new formulation could be widely used in humans."





These straddles allow the investor to profit whether the stock goes up or down. They are computed with the online StraddlesCalc V2 tool.